Literature DB >> 15798849

Leprosy: too complex a disease for a simple elimination paradigm.

Diana N J Lockwood1, Sujai Suneetha.   

Abstract

Can leprosy be eliminated? This paper considers the question against the background of the WHO programme to eliminate leprosy. In 1991 the World Health Assembly set a target of eliminating leprosy as a public health problem by 2000. Elimination was defined as reaching a prevalence of < 1 case per 10 000 people. The elimination programme has been successful in delivering highly effective antibiotic therapy worldwide. However, despite this advance, new-case detection rates remain stable in countries with the highest rates of endemic leprosy, such as Brazil and India. This suggests that infection has not been adequately controlled by antibiotics alone. Leprosy is perhaps more appropriately classed as a chronic stable disease than as an acute infectious disease responsive to elimination strategies. In many countries activities to control and treat leprosy are being integrated into the general health-care system. This reduces the stigma associated with leprosy. However, leprosy causes long-term immunological complications, disability and deformity. The health-care activities of treating and preventing disabilities need to be provided in an integrated setting. Detecting new cases and monitoring disability caused by leprosy will be a challenge. One solution is to implement long-term surveillance in selected countries with the highest rates of endemic disease so that an accurate estimate of the burden of leprosy can be determined. It is also critical that broad-based research into this challenging disease continues until the problems are truly solved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798849      PMCID: PMC2624210          DOI: /S0042-96862005000300018

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  52 in total

1.  Leprosy elimination: not as straightforward as it seemed.

Authors:  Paul R Saunderson
Journal:  Public Health Rep       Date:  2008 Mar-Apr       Impact factor: 2.792

2.  Characterization of MicroRNA Expression Profiles and Identification of Potential Biomarkers in Leprosy.

Authors:  Karina T O S Jorge; Renan P Souza; Marieta T A Assis; Marcelo G Araújo; Massimo Locati; Amélia M R Jesus; Ida M F Dias Baptista; Cristiano X Lima; Antônio L Teixeira; Mauro M Teixeira; Frederico M Soriani
Journal:  J Clin Microbiol       Date:  2017-03-08       Impact factor: 5.948

3.  ML1419c peptide immunization induces Mycobacterium leprae-specific HLA-A*0201-restricted CTL in vivo with potential to kill live mycobacteria.

Authors:  Annemieke Geluk; Susan J F van den Eeden; Karin Dijkman; Louis Wilson; Hee Jin Kim; Kees L M C Franken; John S Spencer; Maria C V Pessolani; Geraldo M B Pereira; Tom H M Ottenhoff
Journal:  J Immunol       Date:  2011-06-24       Impact factor: 5.422

Review 4.  Cutaneous Mycobacterial Infections.

Authors:  Carlos Franco-Paredes; Luis A Marcos; Andrés F Henao-Martínez; Alfonso J Rodríguez-Morales; Wilmer E Villamil-Gómez; Eduardo Gotuzzo; Alexandro Bonifaz
Journal:  Clin Microbiol Rev       Date:  2018-11-14       Impact factor: 26.132

Review 5.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

6.  Subversion of Schwann Cell Glucose Metabolism by Mycobacterium leprae.

Authors:  Rychelle Clayde Affonso Medeiros; Karina do Carmo de Vasconcelos Girardi; Fernanda Karlla Luz Cardoso; Bruno de Siqueira Mietto; Thiago Gomes de Toledo Pinto; Lilian Sales Gomez; Luciana Silva Rodrigues; Mariana Gandini; Julio Jablonski Amaral; Sérgio Luiz Gomes Antunes; Suzana Corte-Real; Patricia Sammarco Rosa; Maria Cristina Vidal Pessolani; José Augusto da Costa Nery; Euzenir Nunes Sarno; Leonardo Ribeiro Batista-Silva; Mauro Sola-Penna; Marcus Fernandes Oliveira; Milton Ozório Moraes; Flavio Alves Lara
Journal:  J Biol Chem       Date:  2016-08-23       Impact factor: 5.157

Review 7.  Teaching of leprosy: current challenges.

Authors:  Cynthia Rossetti Portela Alves; Maria Mônica Freitas Ribeiro; Elza Machado Melo; Marcelo Grossi Araújo
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

8.  Knowledge and Attitude about Leprosy among Indian Dental Students in Faridabad.

Authors:  Meena Jain; Ankur Sharma; Vishal Jain; Karim Virjee; Shilpi Singh
Journal:  J Clin Diagn Res       Date:  2016-03-01

9.  Use of protein antigens for early serological diagnosis of leprosy.

Authors:  Malcolm S Duthie; Wakako Goto; Greg C Ireton; Stephen T Reece; Ludimila P V Cardoso; Celina M T Martelli; Mariane M A Stefani; Maria Nakatani; Robson Crusue de Jesus; Eduardo M Netto; Ma V F Balagon; Esterlina Tan; Robert H Gelber; Yumi Maeda; Masahiko Makino; Dan Hoft; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2007-09-26

10.  Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.

Authors:  Annemieke Geluk; Jolien van der Ploeg; Rose O B Teles; Kees L M C Franken; Corine Prins; Jan Wouter Drijfhout; Euzenir N Sarno; Elizabeth P Sampaio; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2008-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.